100 Participants Needed

Web-Based Tool for Cardiovascular Care in Prostate Cancer

MD
Overseen ByMatthew Doyle
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: Vivek Narayan
Must be taking: ADT
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The overarching goal of this trial is to develop mechanisms to improve cardiovascular care among such prostate cancer patients receiving ADT by increasing patient awareness of individualized cardiovascular risk estimates and mitigation opportunities. Patients will be given access to a web-based quality improvement tool to educate patients of cardiovascular risks in prostate cancer and to inform them of their individualized, estimated cardiovascular risk and guideline-based risk mitigation recommendations. The study will assess the feasibility of this web-based application as a cardiovascular education tool for patients with prostate cancer. The study will also evaluate if completion of the web-based tool improves cardiovascular care access and risk mitigation for patients with prostate cancer.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the CARE-PC Web-Based Application treatment for cardiovascular care in prostate cancer?

The effectiveness of web-based tools in prostate cancer care is supported by studies showing that electronic patient-reported outcomes (ePRO) can improve communication with doctors and enhance patient health. Additionally, decision aids like the Personal Patient Profile-Prostate (P3P) have been shown to reduce decisional conflict in prostate cancer patients, suggesting that similar web-based applications could be beneficial.12345

How does the web-based tool for cardiovascular care in prostate cancer differ from other treatments?

This web-based tool is unique because it focuses on electronic patient-reported outcomes and holistic needs assessment, allowing for personalized and continuous care through remote monitoring and support, unlike traditional paper-based methods.36789

Research Team

Vivek K. Narayan, MD, MS profile ...

Vivek K. Narayan

Principal Investigator

University of Pennsylvania

Eligibility Criteria

This trial is for men over 18 with prostate cancer who are currently on or will start androgen deprivation therapy (ADT) for at least six months. Participants need to be able to read and understand English.

Inclusion Criteria

Patients must be able to read and understand English.

Exclusion Criteria

n/a

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Web-Based Application Participation

Participants use a web-based tool to learn about cardiovascular risks and receive individualized risk estimates and mitigation recommendations

6 months
Online participation

Follow-up

Participants are monitored for changes in cardiovascular care and medication adjustments

18 months

Treatment Details

Interventions

  • CARE-PC Web-Based Application
Trial Overview The CARE-PC study is testing a web-based application designed to educate prostate cancer patients about their cardiovascular risks associated with ADT, provide personalized risk assessments, and offer guidelines for risk reduction.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Men With Prostate Cancer Planned for Receiving ADTExperimental Treatment1 Intervention
Men with prostate cancer \> 18 years of age who are currently receiving or will be receiving treatment with ≥ 6 months of systemic androgen deprivation therapy (ADT).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vivek Narayan

Lead Sponsor

Trials
1
Recruited
100+

National Comprehensive Cancer Network

Collaborator

Trials
121
Recruited
7,400+

Findings from Research

The study developed an electronic registry to monitor men on active surveillance for prostate cancer at a safety-net hospital, aiming to improve adherence to follow-up care and reduce the number of patients lost to follow-up.
By engaging clinic staff in the design process, the registry is tailored to meet specific needs, potentially demonstrating its feasibility for implementation in various healthcare settings and improving patient outcomes.
An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study.Cedars, B., Lisker, S., Borno, HT., et al.[2022]
The web-based P3P decision aid significantly reduced decisional conflict in men with localized prostate cancer compared to usual care, with a notable decrease of 5 points on the decisional conflict scale in the intervention group.
In a study involving 392 men, the P3P aid proved effective in enhancing shared decision-making, with additional factors like income and risk classification influencing the level of decisional conflict experienced by participants.
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.Berry, DL., Hong, F., Blonquist, TM., et al.[2019]
A smartphone application was developed for prostate cancer patients to electronically report their health outcomes, which was evaluated by 21 patients and 10 specialists, showing a high user satisfaction score of 5.95 out of 7.
The application aims to enhance communication between patients and healthcare providers, improve quality of care, and facilitate timely data collection, potentially reducing unnecessary treatment visits and side effects.
Electronic patient-reported outcome (ePRO) application for patients with prostate cancer.Mohseni, M., Ayatollahi, H., Arefpour, AM.[2023]

References

An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study. [2022]
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial. [2019]
Electronic patient-reported outcome (ePRO) application for patients with prostate cancer. [2023]
Receipt of best care according to current quality of care measures and outcomes in men with prostate cancer. [2021]
Digital Medicine in Men with Advanced Prostate Cancer - A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment. [2022]
Patients' experiences of using an e-Health tool for self-management support after prostate cancer surgery: a deductive interview study explained through the FITT framework. [2021]
A Web-Based Prostate Cancer-Specific Holistic Needs Assessment (CHAT-P): Multimethod Study From Concept to Clinical Practice. [2022]
The Internet and prostate cancer patients: searching for and finding information. [2018]
Examining the Priorities, Needs and Preferences of Men with Metastatic Prostate Cancer in Designing a Personalised eHealth Exercise Intervention. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security